Navigation Links
Cara Therapeutics Initiates Phase II Proof-Of-Concept Trial of Novel Analgesic in Acute Post-Operative Pain
Date:1/12/2009

trast to currently marketed opioids, CR845 did not produce inhibition of intestinal transit (ileus) or elicit signs of abuse or addiction liability in animal models. Preclinical studies also indicate that CR845 possesses anti-itch activity.

About Cara Therapeutics

Cara Therapeutics is a privately held biotechnology company focused on developing novel, superior therapeutics to treat pain and inflammation associated with diverse medical conditions. Cara's current pipeline includes near-term clinical drug candidates identified as mechanistically distinct, peripherally-acting analgesics.

Forward-Looking Statements

Certain statements in this press release are forward-looking statements that involve a number of risks and uncertainties. Such forward-looking statements include statements relating to the therapeutic applications of CR845 and about Cara's strategy, technologies, pre-clinical and clinical programs, and ability to identify and develop drugs, as well as other statements that are not historical facts. Actual events or results may differ materially from Cara's expectations. Factors that could cause actual results to differ materially from the forward-looking statements may include, but are not limited to, the timing, success and cost of Cara's research and clinical studies and Cara's ability to obtain additional financing. These forward-looking statements represent Cara's judgment as of the date of this release. Cara disclaims any intent or obligation to update these forward-looking statements.


'/>"/>
SOURCE Cara Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. ExonHit Therapeutics Expands Strategic Collaboration With Allergan
2. Synvista Therapeutics Announces Published Data Demonstrating Elevation of Carboxymethyl-Lysine (CML) Is Associated with Decline in Renal Function and Arterial Stiffness in Older Adults
3. Synvista Therapeutics Announces First Dosing of SYI-2074 in Clinical Trial for Psoriasis
4. Halozyme Therapeutics Begins Phase 1 Clinical Trial of Bisphosphonate Administered With rHuPH20 Enzyme
5. Halozyme Therapeutics Announces Roche Begins Phase 1 Clinical Trial and Selects Fourth Exclusive Biologic Target
6. Orexigen(R) Therapeutics Announces Changes to Its Clinical Programs and Management Team
7. TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint in a Phase II Clinical Trial in Patients with Xerostomia
8. Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints
9. Duska Therapeutics Applies for Phase 3 Special Protocol Assessment
10. Alba Therapeutics Announces Enrollment of Its First European Patient in Global Phase IIb Study of Larazotide Acetate for Treatment of Active Celiac Disease
11. Cell Therapeutics Pixantrone Phase III (EXTEND) Pivotal Trial Successful in Achieving Primary Endpoint

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...--Reportlinker.comannouncesthatanewmarketresearchr...isposables-AWorldMarketReview ,, http://www....-A-World-Market-Review.html#utm_source=prnewswire&...,, Globalgeneralanesthesiadisposablesmarketisch...siderablerisewitnessedingeneralsurgicalprocedures,...
(Date:11/23/2009)...wswire/--LightSciencesOncology,Inc.(LSO)todayannou...lekta,toanewlycreatedseatonitsboardofdirectors.Mr....uctcompanies,includingElekta,tomarketleadership. ,...strengthinbusinessdevelopmenttotheboard,"saidLSO,s...eaderincancer-therapybusinessdevelopment.Hehasover...
(Date:11/23/2009)...ewswire-FirstCall/-- CumberlandPharmaceuticalsInc....sfromastudyevaluatingthesafetyandefficacyofCaldolo...edburnpatients. ,, Statisticalsignificancewasac...tientsoverthefirst24hoursoftreatment.Thestudyevalu...scoveringmorethan10percenttotalbodysurfacearea.Oth...
Breaking Medicine Technology:Reportlinker Adds Anesthesia Disposables - A World Market Review 2Reportlinker Adds Anesthesia Disposables - A World Market Review 3Reportlinker Adds Anesthesia Disposables - A World Market Review 4Reportlinker Adds Anesthesia Disposables - A World Market Review 5Reportlinker Adds Anesthesia Disposables - A World Market Review 6Light Sciences Oncology Elects Akbar Seddigh, Chairman of Elekta AB to Its Board of Directors 2Caldolor(R) (Ibuprofen) Injection Demonstrates Significant Fever Reduction in Hospitalized Burn Patients 2Caldolor(R) (Ibuprofen) Injection Demonstrates Significant Fever Reduction in Hospitalized Burn Patients 3Mettler Toledo International Inc Announces Webcast of Presentation at Baird Industrial Conference 5968 1Cambrex Reports Third Quarter 2009 Results 5965 1Cambrex Reports Third Quarter 2009 Results 5965 2Cambrex Reports Third Quarter 2009 Results 5965 3Cambrex Reports Third Quarter 2009 Results 5965 4Cambrex Reports Third Quarter 2009 Results 5965 5Cambrex Reports Third Quarter 2009 Results 5965 6Cambrex Reports Third Quarter 2009 Results 5965 7Cambrex Reports Third Quarter 2009 Results 5965 8Cambrex Reports Third Quarter 2009 Results 5965 9Cambrex Reports Third Quarter 2009 Results 5965 10Cambrex Reports Third Quarter 2009 Results 5965 11Study 3A Lap band surgery effective for morbidly obese children 60640 1
..., June 27, 2007-Organon, the human,healthcare busi...out of three Phase III clinical trials with corifo...ility hormone, have reached,their randomization ta...t fertility hormone. It is,the first of a new clas...nt or SFS) of which, due to its long half-life, on...
...and BASEL, Switzerland, June 27 /CNW/ -,Aspreva Ph... and,Roche today released preliminary results for ...olate mofetil, MMF) to intravenous,cyclophosphamid...r,inducing treatment response in the induction pha...though response rates were similar in both arms, t...
Other Medicine Technology:Two Phase III clinical trials on corifollitropin alfa (Org 36286),reach randomization target 2Two Phase III clinical trials on corifollitropin alfa (Org 36286),reach randomization target 3Aspreva and Roche Announce Preliminary Results for Phase III Study,Evaluating CellCept in Lupus Nephritis 2Aspreva and Roche Announce Preliminary Results for Phase III Study,Evaluating CellCept in Lupus Nephritis 3Aspreva and Roche Announce Preliminary Results for Phase III Study,Evaluating CellCept in Lupus Nephritis 4Aspreva and Roche Announce Preliminary Results for Phase III Study,Evaluating CellCept in Lupus Nephritis 5Aspreva and Roche Announce Preliminary Results for Phase III Study,Evaluating CellCept in Lupus Nephritis 6Aspreva and Roche Announce Preliminary Results for Phase III Study,Evaluating CellCept in Lupus Nephritis 7Aspreva and Roche Announce Preliminary Results for Phase III Study,Evaluating CellCept in Lupus Nephritis 8
(Date:11/23/2009)...r 23, 2009 In the November issue of GIE: Gastroi...ientific journal of the American Society for Gastr...ord University found that Barrett,s esophagus was ...rgoing endoscopic screening. Also in this issue, t...esearchers from France, in the largest single-cent...
(Date:11/23/2009)...al College of Georgia is leading an initiative tha...patients with sickle cell disease. , Morehouse ...orida are partners in the initiative that is enlis...ve as "medical homes" for patients, changing how p...to the hospital and seeking better prevention and ...
(Date:11/23/2009)...What could have been a simple case for a New York ...nto a murder charge. , Ne...e been a case for New York auto accident attorney...ent of road rage turned fatal., , , , ,According ...yn driver was shot and killed during a heated road...
(Date:11/23/2009)...Nov.23/PRNewswire/--XiotechCorporationtodayannounc...rise(TM)7000storagesystem,poweredbyIntelligentStor...atastorageneeds,enablefuturegrowthanddeliversignif...datacenter. ,, MasonGeneral,locatedinShelton,Wa...azine,s"MostWired-Rural"hospitalsin2008and2009fori...
(Date:11/23/2009)...hat adding flaxseed oil to the diet could reduce t...nd women with diabetes, according to a report to b...Safety, Nutrition and Public Health . , Mer Harv...in Cairo, Egypt, have studied the effect of diabet...n the diet might delay the onset of osteoporosis. ...
Breaking Medicine News(10 mins):Health News:Study highlights from November issue of GIE: Gastrointestinal Endoscopy 2Health News:Study highlights from November issue of GIE: Gastrointestinal Endoscopy 3Health News:Study highlights from November issue of GIE: Gastrointestinal Endoscopy 4Health News:Study highlights from November issue of GIE: Gastrointestinal Endoscopy 5Health News:Initiative could result in paradigm shift in the care of sickle cell patients 2Health News:Initiative could result in paradigm shift in the care of sickle cell patients 3Health News:Initiative could result in paradigm shift in the care of sickle cell patients 4Health News:Initiative could result in paradigm shift in the care of sickle cell patients 5Health News:An Incident of Road Rage Turns Into Murder 2Health News:ISE Technology by Xiotech Helps Hospital Achieve Data Center Efficiency, Savings 2Health News:Flaxseed oil and osteoporosis 2
...unique one-stop store for diabetes care, that incl...althcare books, was opened here Tuesday. // T...to-Health, a company involved in the distribution ...ts, jams and honey. Sugar-free toothpaste is also ...
...N1 swine influenza virus in domestic pigs has been...November 2006 issue of the Journal of clinical //m...nd colleagues at Pukyong National University. ...sortment of influenza viruses. The virus, which wa...
...team of researchers led by an Indian American scie...nseeds, potentially unlocking a large source of nu...obally vital textile crop. The leftover cottonseed...cottonseeds, Keerti Rathore and colleagues from th...
...searchers from the psychiatry department and Brain...sh Columbia conducted a study on mice which portra...e. During the study, the researchers allowed... levels of oxygen. After a month had elapsed...
... a report that might alert the antennae of call ce... the apathy of nearly two-thirds of call // center...ne precious little to prevent hearing damage in th...ty of theirs, gravely. Employers are legally...
...century ago this month, German psychiatrist Alois ...e neurodegenerative disease //which ultimately cam... learn about Alzheimer's disease and develop treat...ed university professor of biological sciences at ...
Other Medicine News:Health News:Yeast Model Shows Promise as Alzheimer's Test 2
Betasept® Scrub
Scrub Care® Brand Clean Care™
Scrub Care Scrub Brushes & Solutions
...ealthcare associated infections can be prevented w...most important action a healthcare worker can do t...giene. Alcohol gel hand sanitization is fast, easy...g with soap and water. , Aplicare's 62% Ethyl...
Medicine Products: